Eparation Amp Purification News Today

In a recent interview, Hayley Crowe, head of Ecolab's global life sciences business, shed light on Purolite's latest developments and its significant contributions to the biopharmaceutical industry.

Cytiva and the life sciences business of Pall Corporation are now united as one business under the Cytiva brand, with the completion of the integration announced this morning. Emmanuel Ligner, Danaher Group Executive, President and CEO of Cytiva, tells us how the company will focus its efforts moving forward to support long-term growth of the biotech industry.

Meissner Corporation – a company which manufactures advanced microfiltration and therapeutic manufacturing systems for pharmaceutical drugs, therapeutics, biologics, and cell and gene therapies - will invest nearly $250m in a new manufacturing facility in Athens-Clarke County in the US.

Purolite develops and manufactures resin beads used in the most regulated industries to separate, remove or recover very specific elements and compounds. Purolite produces more than 1,000 active commercial products.

Starting with the end in mind when choosing mRNA raw materials help mitigate costly risks. Seeking quality attributes that go beyond GMP grade is key.

Donaldson Company, Inc., a global provider of filtration products and solutions, has acquired Solaris Biotechnology Srl for around €41m ($46m).

We track some of the more recent developments in biopharma manufacturing tech.

Raw materials play a vital role in the development of cell and gene (CGT) therapies.

What are some of dos and don’ts on starter materials for CGT manufacturing? Raw materials play a vital role in the development of cell and gene (CGT) therapies. Mike Brewer, director, global principal consultant, regulatory, bioproduction, Thermo Fisher Scientific, spoke to BioPharma-Reporter about some of dos and don’ts on starter materials for CGT manufacturing. His advice is particularly targeted at newer entrants to the CGT space, those at the at the preclin...

Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group French pharma services provider, Clean Biologics, has acquired Canadian CDMO, Biodextris, in a move it says will boost its analytical and process development, and early-phase clinical manufacturing and quality control testing services for clients in the vaccine and biologics industries. The move also means it gets a platform to establish a presence on the North A...